White paper

Showing 8 posts of 23 posts found.

Outcomes based measures for Pharma new commercial models

September 29, 2010
Sales and Marketing Kinapse, White paper

It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …

New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale

September 29, 2010
Sales and Marketing Kinapse, White paper

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …

Realising outsourcing’s potential

September 20, 2010
Sales and Marketing Kinapse, White paper

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010
Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 1

August 11, 2010
Research and Development Kinapse, life sciences, pharma

Valuations are essential components of effective transactions in the life sciences industry

Latest content